Abstract
Perhaps more than any other tumor marker associated with hematological neoplasia, the PMLIRAR-α hybrid gene has been shown to be important in the chinical practice. This aberration is absolutely APL-specific, being found in virtually 100% of cases and in no other tumors. Secondly, it identifies a clinical entity that is unique in its response to a specific treatment, i.e., the differentiative agent all-trans retinoic acid (ATRA). As the disease frequently presents with a life-threatening hemorrhagic diathesis, its prompt recognition in order to start the specific treatment is mandatory (1, 2). In this respect, reverse-transcription polymerase chain reaction (RT-PCR) amphficatron of the specific fusion gene represents an extremely useful diagnostic tool. Finally, several groups have independently reported that RT-PCR monitoring studies of residual disease in APL provide important prognostic informations, by predicting hematologic relapse in patients who test positive during clinical remission (3–5).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Warrel, R. P., Jr., de Thé, H, Wang, Z.-Y., and Degos, L (1993) Acute promyelocytic leukemia. N. Engl. J Med 329, 177–89.
Grignani, F., Fagioli, M., Alcalay, M., Longo, L., Pandolfi, P P., Donti, E., Biondi, A., LoCoca, F., Grignani, F., and Pelicci, P. G (1994) Acute promyelocytic leukemia: from genetics to treatment. Blood 83, 10–25.
Lo Coca, F., Diverio, D., Pandolfi, P. P., Biondi, A., Rossi, V., Awisati, G, Rambaldi, A., Arcese, W., Petti, M. C., Meloni, G., Mandelli, F., Grignani, F., Masera, G., Barbui, T., and Pelicci, P G. (1992) Molecular evaluation of residual disease as predictor of relapse in acute promyelocytic leukemia. Lancet 340, 1437,1438.
Chang, K. S., Lu, J., Wang, G., Trujillo, J. M., Estey, E., Cork, A., Chu, D T., Freireich, E. J., and Stass, S. A. (1992) The t(15; 17) breakpoint in acute promyelocytic leukemia cluster within two different sites of the my1 gene Targets for the detection of minimal residual disease by polymerase chain reaction. Blood 79, 554.
Miller, W. H., Jr, Levine, K., DeBlasio, A., Frankel, S. R., Dmitrovsky, E, and Warrel, R P., Jr. (1993) Detection of minimal residual disease in acute promyelocytlc leukemia by reverse transcription polymerase chain reaction assay for the PMLIRAR-α fusion mRNA Blood 82, 1689–1694
Miller, W. H., Jr, Kaktzuka, A., Frankel, S. R., Warrel, R. P., Jr., De Blasio, A, Levine, K, Evans, R M., and Dimitrovsky, E (1992) Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocyttc leukemia. Proc Natl. Acad Scz USA 89, 2694
Chomczynsky, P. and Saccht, N. (1987) Single step method of RNA isolation by guamdtum thiocyanate-phenol-chloroform extraction Anal. Blochem 162, 156–158.
Mamatis, T., Fritsch, E. F., and Sambrook, J (1982) Molecular CZonzng A Laboratory Manual Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Pandolfi, P P, Alcalay, M, Fagioli, M., Zangrilli, D, Mencarelli, A., Diverio, D., Biondi, A, Lo Coca, F, Rambaldi, A., Grignani, F., Rochette-Egly, C, Gaube, M. P., Chambon, P., and Pelicci, P. G. (1992) Genomic variability and alternative splicing generate multrple PMLIRAR-α transcripts that encode aberrant PML proteins and PMLIRAR-α isoforms in acute promyelocytic leukaemta. EMBO J 1, 1397.
Biondi, A., Rambaldi, A., Pandolfi, P P., Rossi, V, Giudici, G, Alcalay, M., LoCoca, F., Diverto, D., Pogliani, E M., Lanzi, E M., Mandelli, F, Masera, G., Barbui, T., and Pelicci, P G. (1992) Molecular momtormg of the myl/RAR-α fusion gene in acute preomyelocytic leukemia by polymerase chain reaction Blood 80, 492.
Castatgne, S., Balitrand, N., de Thé, H., Dejean, A., Degos, L., and Chomienne, C. (1992) A PML-Retinoic acid receptor alpha fusion transcripts is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia. Blood 79, 3110.
Chen, S-J., Chen, Z., Chen, A., Tong, J-H., Dong, S., Wang, Z-Y, Waxman, S., and Zelent, A. (1992) Occurrence of distinct PML-RAR-α isoforms in patients with acute promyelocytic leukemia detected by reverse transcrtptase/polymerase chain reaction Oncogene 7, 1223.
Huang, W, Sun, G.-L., Li, X.-S., Cao, Q., Lu, Y., Jang, G-S., Zhang, F-Q., Chat, J.-R., Wang, Z-Y., Waxman, S., Chen, Z., and Chen, S.-J, (1993) Acute promyelocytrc leukemia relevance of two major PML-RAR-α isoforms and detection of minimal residual disease by reverse transcrtptase-polymerase chain reactton to predict relapse. Blood 82, 1264–1269
Melo, J. V., Kent, N. S., Yan, X.-H., and Goldman, J. M. (1994) Controls for reverse transcriptase-polymerase chain reaction amplificatton of BCR-ABL transcripts. Blood 84, 3984–3986.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Diverio, D., Luciano, A., Riccioni, R., Coco, F.L., Biondi, A. (1996). Analysis of the PML/RAR-α Fusion Gene in Acute Promyelocytic Leukemia by Reverse-Transcription Polymerase Chain Reaction. In: Cotter, F.E. (eds) Molecular Diagnosis of Cancer. Methods in Molecular Medicine™, vol 6. Humana Press. https://doi.org/10.1385/0-89603-341-4:47
Download citation
DOI: https://doi.org/10.1385/0-89603-341-4:47
Publisher Name: Humana Press
Print ISBN: 978-0-89603-341-2
Online ISBN: 978-1-59259-590-7
eBook Packages: Springer Protocols